← Home
/
Can-Fite BioPharma Ltd. (CANF)
Stock Analysis
Can-Fite BioPharma Ltd. (CANF)
CANF
CANF · Market data
3.07
+1.32%
Updated: 2026-06-18 17:26 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
✓
Fundamentals
Insufficient / Negative
✓
Price Structure
Vulnerable
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
3.16
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving CANF?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.16 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
💵 Revenue
202,000
≈ Insufficient
📈 Net Income
-4.88M
↘ Negative
🧮 EPS (Basic)
0.00
↘ Negative
Note: This is an algorithmic technical snapshot, not financial advice.